Clinical Trials Browser

Interventional × Myelodysplastic Syndromes × Immunotherapy, Adoptive × Clear all

NCT03291444 2024-03-15

CAR-T Cells Combined With Peptide Specific Dendritic Cell in Relapsed/Refractory Leukemia/MDS

Phase 1 Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute